Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors

Antonio Francavilla, Alessandro Azzarone, Guiseppe Carrieri, Carlo Scotti-Foglieni, Qia Hua Zeng, Umberto Cillo, Kendrick Porter, Thomas E. Starzl

Research output: Contribution to journalArticle

Abstract

Transforming growth factor-β canceled the hepatocyte proliferation caused by transforming growth factor-α when the two substances were mixed and administered through a disconnected central portal vein branch after creation of an Eck fistula. In contrast, transforming growth factor-β had no antidotal action on the stimulatory effects of insulin or full test doses of insulinlike factor-2, hepatocyte growth factor, epidermal growth factor or triiodothymanine. A minor antidotal effect on hepatic stimulatory substance activity could be detected, but only with hepatic stimulatory substance was given in doses smaller than those known to cause maximum stimulatory response. These results suggest a highly specific pharmacological and physiological interaction between transforming growth factor-α and transforming growth factor-β in the modulation of liver growth control.

Original languageEnglish
Pages (from-to)1267-1270
Number of pages4
JournalHepatology
Volume16
Issue number5
Publication statusPublished - Nov 1992

Fingerprint

Surgical Portacaval Shunt
Transforming Growth Factors
Canidae
Intercellular Signaling Peptides and Proteins
Liver
Hepatocyte Growth Factor
Portal Vein
Epidermal Growth Factor
Hepatocytes
Pharmacology
Insulin
Growth

ASJC Scopus subject areas

  • Hepatology

Cite this

Francavilla, A., Azzarone, A., Carrieri, G., Scotti-Foglieni, C., Zeng, Q. H., Cillo, U., ... Starzl, T. E. (1992). Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors. Hepatology, 16(5), 1267-1270.

Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors. / Francavilla, Antonio; Azzarone, Alessandro; Carrieri, Guiseppe; Scotti-Foglieni, Carlo; Zeng, Qia Hua; Cillo, Umberto; Porter, Kendrick; Starzl, Thomas E.

In: Hepatology, Vol. 16, No. 5, 11.1992, p. 1267-1270.

Research output: Contribution to journalArticle

Francavilla, A, Azzarone, A, Carrieri, G, Scotti-Foglieni, C, Zeng, QH, Cillo, U, Porter, K & Starzl, TE 1992, 'Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors', Hepatology, vol. 16, no. 5, pp. 1267-1270.
Francavilla A, Azzarone A, Carrieri G, Scotti-Foglieni C, Zeng QH, Cillo U et al. Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors. Hepatology. 1992 Nov;16(5):1267-1270.
Francavilla, Antonio ; Azzarone, Alessandro ; Carrieri, Guiseppe ; Scotti-Foglieni, Carlo ; Zeng, Qia Hua ; Cillo, Umberto ; Porter, Kendrick ; Starzl, Thomas E. / Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors. In: Hepatology. 1992 ; Vol. 16, No. 5. pp. 1267-1270.
@article{c7afd90954b24e45bdf8af67afcb7761,
title = "Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors",
abstract = "Transforming growth factor-β canceled the hepatocyte proliferation caused by transforming growth factor-α when the two substances were mixed and administered through a disconnected central portal vein branch after creation of an Eck fistula. In contrast, transforming growth factor-β had no antidotal action on the stimulatory effects of insulin or full test doses of insulinlike factor-2, hepatocyte growth factor, epidermal growth factor or triiodothymanine. A minor antidotal effect on hepatic stimulatory substance activity could be detected, but only with hepatic stimulatory substance was given in doses smaller than those known to cause maximum stimulatory response. These results suggest a highly specific pharmacological and physiological interaction between transforming growth factor-α and transforming growth factor-β in the modulation of liver growth control.",
author = "Antonio Francavilla and Alessandro Azzarone and Guiseppe Carrieri and Carlo Scotti-Foglieni and Zeng, {Qia Hua} and Umberto Cillo and Kendrick Porter and Starzl, {Thomas E.}",
year = "1992",
month = "11",
language = "English",
volume = "16",
pages = "1267--1270",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Effect on the canine Eck fistula liver of intraportal TGF-β alone or with hepatic growth factors

AU - Francavilla, Antonio

AU - Azzarone, Alessandro

AU - Carrieri, Guiseppe

AU - Scotti-Foglieni, Carlo

AU - Zeng, Qia Hua

AU - Cillo, Umberto

AU - Porter, Kendrick

AU - Starzl, Thomas E.

PY - 1992/11

Y1 - 1992/11

N2 - Transforming growth factor-β canceled the hepatocyte proliferation caused by transforming growth factor-α when the two substances were mixed and administered through a disconnected central portal vein branch after creation of an Eck fistula. In contrast, transforming growth factor-β had no antidotal action on the stimulatory effects of insulin or full test doses of insulinlike factor-2, hepatocyte growth factor, epidermal growth factor or triiodothymanine. A minor antidotal effect on hepatic stimulatory substance activity could be detected, but only with hepatic stimulatory substance was given in doses smaller than those known to cause maximum stimulatory response. These results suggest a highly specific pharmacological and physiological interaction between transforming growth factor-α and transforming growth factor-β in the modulation of liver growth control.

AB - Transforming growth factor-β canceled the hepatocyte proliferation caused by transforming growth factor-α when the two substances were mixed and administered through a disconnected central portal vein branch after creation of an Eck fistula. In contrast, transforming growth factor-β had no antidotal action on the stimulatory effects of insulin or full test doses of insulinlike factor-2, hepatocyte growth factor, epidermal growth factor or triiodothymanine. A minor antidotal effect on hepatic stimulatory substance activity could be detected, but only with hepatic stimulatory substance was given in doses smaller than those known to cause maximum stimulatory response. These results suggest a highly specific pharmacological and physiological interaction between transforming growth factor-α and transforming growth factor-β in the modulation of liver growth control.

UR - http://www.scopus.com/inward/record.url?scp=0026456966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026456966&partnerID=8YFLogxK

M3 - Article

C2 - 1427665

AN - SCOPUS:0026456966

VL - 16

SP - 1267

EP - 1270

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -